CSTM vs. UAMY

Last updated Apr 1, 2026

Compare and contrast key facts about Constellium SE (CSTM) and United States Antimony Corporation (UAMY).

Performance

CSTM vs. UAMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Constellium SE (CSTM) and United States Antimony Corporation (UAMY). The values are adjusted to include any dividend payments, if applicable.

CSTM vs. UAMY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CSTM Constellium SE	30.40%	83.54%	-48.55%	68.72%	-33.95%	28.02%	4.40%	91.70%	-37.31%	88.98%
UAMY United States Antimony Corporation	73.90%	183.62%	610.84%	-48.86%	-2.19%	-4.64%	35.58%	-33.62%	81.25%	27.49%

Fundamentals

Market Cap CSTM : $3.49B UAMY : $1.08B
EPS CSTM : $1.63 UAMY : -$0.03
PS Ratio CSTM : 0.49 UAMY : 27.74
PB Ratio CSTM : 4.31 UAMY : 7.66
Total Revenue (TTM) CSTM : $7.19B UAMY : $39.26M
Gross Profit (TTM) CSTM : $729.39M UAMY : $9.87M
EBITDA (TTM) CSTM : $684.28M UAMY : -$6.89M

Returns By Period

In the year-to-date period, CSTM achieves a 30.40% return, which is significantly lower than UAMY's 73.90% return. Over the past 10 years, CSTM has underperformed UAMY with an annualized return of 17.03%, while UAMY has yielded a comparatively higher 43.25% annualized return.

CSTM

• 1D: 6.59%
• 1M: -1.25%
• YTD: 30.40%
• 6M: 65.19%
• 1Y: 143.61%
• 3Y*: 17.17%
• 5Y*: 10.56%
• 10Y*: 17.03%

UAMY

• 1D: 10.93%
• 1M: -2.35%
• YTD: 73.90%
• 6M: 40.81%
• 1Y: 296.82%
• 3Y*: 184.93%
• 5Y*: 48.97%
• 10Y*: 43.25%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CSTM vs. UAMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CSTM

CSTM Risk / Return Rank: 94
CSTM Sharpe Ratio Rank: 96
CSTM Sortino Ratio Rank: 94
CSTM Omega Ratio Rank: 91
CSTM Calmar Ratio Rank: 95
CSTM Martin Ratio Rank: 97

UAMY

UAMY Risk / Return Rank: 88
UAMY Sharpe Ratio Rank: 93
UAMY Sortino Ratio Rank: 90
UAMY Omega Ratio Rank: 85
UAMY Calmar Ratio Rank: 90
UAMY Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CSTM vs. UAMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Constellium SE (CSTM) and United States Antimony Corporation (UAMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CSTM	UAMY	Difference
Sharpe ratio Return per unit of total volatility	2.85	2.28	+0.58
Sortino ratio Return per unit of downside risk	3.30	2.80	+0.50
Omega ratio Gain probability vs. loss probability	1.41	1.32	+0.08
Calmar ratio Return relative to maximum drawdown	5.49	3.81	+1.68
Martin ratio Return relative to average drawdown	20.89	7.11	+13.77
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CSTM vs. UAMY - Sharpe Ratio Comparison

The current CSTM Sharpe Ratio is 2.85, which is comparable to the UAMY Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of CSTM and UAMY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CSTM	UAMY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.85	2.28	+0.58
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.23	0.53	-0.30
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.30	0.43	-0.13
Sharpe Ratio (All Time) Calculated using the full available price history	0.07	0.07	0.00

Correlation

The correlation between CSTM and UAMY is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CSTM vs. UAMY - Dividend Comparison

Neither CSTM nor UAMY has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

CSTM vs. UAMY - Drawdown Comparison

The maximum CSTM drawdown since its inception was -88.70%, smaller than the maximum UAMY drawdown of -96.44%. Use the drawdown chart below to compare losses from any high point for CSTM and UAMY.

Drawdown Indicators

	CSTM	UAMY	Difference
Max Drawdown Largest peak-to-trough decline	-88.70%	-96.44%	+7.74%
Max Drawdown (1Y) Largest decline over 1 year	-25.24%	-74.30%	+49.06%
Max Drawdown (5Y) Largest decline over 5 years	-66.35%	-84.49%	+18.14%
Max Drawdown (10Y) Largest decline over 10 years	-72.30%	-89.76%	+17.46%
Current Drawdown Current decline from peak	-24.11%	-50.03%	+25.92%
Average Drawdown Average peak-to-trough decline	-54.51%	-66.58%	+12.07%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.64%	39.77%	-33.13%

Volatility

CSTM vs. UAMY - Volatility Comparison

The current volatility for Constellium SE (CSTM) is 16.98%, while United States Antimony Corporation (UAMY) has a volatility of 40.32%. This indicates that CSTM experiences smaller price fluctuations and is considered to be less risky than UAMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CSTM	UAMY	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.98%	40.32%	-23.34%
Volatility (6M) Calculated over the trailing 6-month period	31.71%	107.33%	-75.62%
Volatility (1Y) Calculated over the trailing 1-year period	50.71%	131.50%	-80.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	46.36%	93.58%	-47.22%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	56.52%	100.37%	-43.85%

Financials

CSTM vs. UAMY - Profitability Comparison

The chart below illustrates the profitability comparison between Constellium SE and United States Antimony Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CSTM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Constellium SE reported a gross profit of -110.61M and revenue of 942.94M. Therefore, the gross margin over that period was -11.7%.

UAMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, United States Antimony Corporation reported a gross profit of 2.65M and revenue of 13.03M. Therefore, the gross margin over that period was 20.3%.

CSTM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Constellium SE reported an operating income of 88.42M and revenue of 942.94M, resulting in an operating margin of 9.4%.

UAMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, United States Antimony Corporation reported an operating income of -3.92M and revenue of 13.03M, resulting in an operating margin of -30.1%.

CSTM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Constellium SE reported a net income of 71.35M and revenue of 942.94M, resulting in a net margin of 7.6%.

UAMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, United States Antimony Corporation reported a net income of -286.91K and revenue of 13.03M, resulting in a net margin of -2.2%.